Published in Biol Psychiatry on November 01, 1994
The effects of antihypertensive therapy on the quality of life. N Engl J Med (1986) 5.32
The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry (1965) 5.09
Biogenic amines and emotion. Science (1967) 3.49
Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med (1981) 2.89
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med (1987) 2.83
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA (1997) 2.80
Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry (2000) 2.70
Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res (1999) 2.49
Screening for lung cancer re-examined. A reinterpretation of the Mayo Lung Project randomized trial on lung cancer screening. Chest (1993) 2.35
DNA replication licensing and human cell proliferation. J Cell Sci (2001) 2.30
Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med (1980) 2.15
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry (1998) 2.13
Spontaneous recurrent hypothermia accompanying agenesis of the corpus callosum. Brain (1969) 2.10
Screening for lung cancer. Another look; a different view. Chest (1997) 2.09
Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med (1981) 1.97
Cdc6 protein causes premature entry into S phase in a mammalian cell-free system. EMBO J (1998) 1.95
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation (1981) 1.90
Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochem Pharmacol (1968) 1.86
Accentuated vascular and endocrine response to SQ 20881 in hypertension. N Engl J Med (1977) 1.83
Validation of the tracer-balance concept with reference to leucine: 24-h intravenous tracer studies with L-[1-13C]leucine and [15N-15N]urea. Am J Clin Nutr (1994) 1.78
Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest (1980) 1.76
Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry Suppl (1998) 1.73
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68
Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med (1973) 1.65
Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension (1999) 1.64
The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis. J Lab Clin Med (1972) 1.62
Social functioning in depression: a review. J Clin Psychiatry (2000) 1.62
Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study. Am J Psychiatry (2000) 1.61
Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest (1974) 1.59
Chest X-ray screening improves outcome in lung cancer. A reappraisal of randomized trials on lung cancer screening. Chest (1995) 1.56
The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. Biochem Pharmacol (1967) 1.54
Gender differences in chronic major and double depression. J Affect Disord (2000) 1.53
Familial hypo-beta-lipoproteinemia: a genetic disorder of lipid metabolism with nervous system involvement. Am J Med (1969) 1.51
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology (2000) 1.50
Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. N Engl J Med (1984) 1.49
Chronologic and physiologic age affect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors. Science (1978) 1.48
Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (1997) 1.46
Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J Affect Disord (1999) 1.45
Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs. J Mol Med (Berl) (2001) 1.43
Dilative cardiomyopathy leading to congestive heart failure in a male squirrel monkey (Saimiri sciureus). J Med Primatol (2000) 1.42
Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry (2010) 1.42
Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol. Mol Psychiatry (2007) 1.40
Psychopharmacological screening criteria. APA Committee on Research on Psychiatric Treatments. J Clin Psychiatry (1992) 1.39
Glucocorticoid-remediable aldosteronism. Cardiovasc Res (1996) 1.38
The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol (1999) 1.38
Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res (2001) 1.34
Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med (1981) 1.33
A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res (1985) 1.33
Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension (1981) 1.31
Pathophysiology of spironolactone-induced gynecomastia. Ann Intern Med (1977) 1.31
Early life stress and inherited variation in monkey hippocampal volumes. Arch Gen Psychiatry (2001) 1.29
Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. Neuropathol Appl Neurobiol (2001) 1.28
Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension. N Engl J Med (1979) 1.27
Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation (1993) 1.26
Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res (2001) 1.26
Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose. Diabetes (1984) 1.26
Reproducibility of hemoglobin AIc and sensitivity to various degrees of glucose intolerance. Ann Intern Med (1979) 1.25
Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. Lancet (1999) 1.24
Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation. Hypertension (1981) 1.23
Temporal relationship of glycosylated haemoglobin concentrations to glucose control in diabetics. Diabetologia (1979) 1.22
Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harv Rev Psychiatry (1999) 1.21
Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol (2001) 1.21
Regulation of aldosterone secretion. Annu Rev Physiol (1988) 1.20
Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading. J Clin Invest (1972) 1.20
Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus. Diabetes (1984) 1.20
Potassim-aldosterone-renin interrelationships. J Clin Endocrinol Metab (1975) 1.20
Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int (1981) 1.20
Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes (1976) 1.19
Stress-induced changes in primate prefrontal profiles of gene expression. Mol Psychiatry (2007) 1.18
Corticosteroids and cognition. J Psychiatr Res (2001) 1.18
Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Invest (1975) 1.16
Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man. J Clin Invest (1976) 1.16
Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest (1983) 1.16
Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens (1996) 1.16
Heterogenous inositol tetrakisphosphate binding sites in the adrenal cortex. J Biol Chem (1988) 1.15
Benzodiazepines in depressive disorders. Arch Gen Psychiatry (1978) 1.15
Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry (2000) 1.15
Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. Arch Intern Med (1999) 1.15
24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry (2000) 1.15
The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965. J Neuropsychiatry Clin Neurosci (1995) 1.14
Nephrotoxicity from angiographic contrast material. A prospective study. Am J Med (1982) 1.13
Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake. J Hypertens (2001) 1.12
Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension (1998) 1.12
DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer (2005) 1.12
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens (2006) 1.12
Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes (1978) 1.12
The clinical course of diabetic nephropathy. JAMA (1976) 1.10
Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension (1999) 1.09
Studies of the control of plasma aldosterone concentration in normal man. II. Effect of dietary potassium and acute potassium infusion. J Clin Invest (1972) 1.09
Melatonin rhythm observed throughout a three-cycle bright-light stimulus designed to reset the human circadian pacemaker. J Biol Rhythms (1999) 1.09
Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers. Neurology (2005) 1.07
The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment. Psychopharmacol Bull (1974) 1.06
Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications. Ann Rheum Dis (1986) 1.06
Monozygotic triplets with discordance for diabetes mellitus and diabetic microangiopathy. Diabetes (1977) 1.05
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. J Clin Psychiatry (1998) 1.05
Calcium oscillations in single adrenal glomerulosa cells stimulated by angiotensin II. Proc Natl Acad Sci U S A (1988) 1.04
Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose. J Clin Invest (1968) 1.04